Management evolution of pulmonary atresia and intact ventricular septum.
To examine the impact on survival and clinical course of incorporating the morphologic classification of the right ventricle into the evolving management strategy for babies with pulmonary atresia and intact ventricular septum, the surgical results and follow-up status of the first 62 consecutive patients managed in this hospital between 1979 and 1990 were reviewed. Before 1984, all 23 babies from group I underwent primary right ventricular outflow reconstruction irrespective of right ventricular morphology and size. Since 1984, depending on the morphology and size of the right ventricle, 39 babies from group II had either closed transventricular pulmonary valvotomy (n = 31) or a shunt operation (n = 8). There were 10 hospital (43%) and 2 late deaths (total mortality 52%) in our group I patients. Three of the 11 long-term survivors had cyanosis at rest but none had any residual pressure gradient across the pulmonary outflow. Group II had 6 hospital (15%) and 4 late deaths (total mortality = 26%). Of the 29 long-term survivors, 9 had a second-stage right ventricular outflow reconstruction, 8 had balloon valvuloplasty and 2 had successful Fontan operation. At the latest follow-up, 5 children from this group have cyanosis at rest, 1 has a residual gradient (55 mm Hg) across the infundibulum, and 3 have right ventricular dysfunction. The hospital and total mortality for babies in group II was significantly lower than that in group I (p < 0.01). These data suggest that tailoring the treatment to the right ventricular anatomy results in a lower overall mortality although long term postoperative hemodynamic abnormalities are observed in both groups.
Leung
M P
MP
Department of Paediatrics, Grantham Hospital, University of Hong Kong, Aberdeen.
Mok
C K
CK
Lee
J
J
Lo
R N
RN
Cheung
H
H
Chiu
C
C
D000015:Abnormalities, Multiple / Q000401:mortality / Q000601:surgery*; D005500:Follow-Up Studies; D006344:Heart Septal Defects, Atrial; D006346:Heart Septum / Q000473:pathology; D006352:Heart Ventricles / Q000002:abnormalities* / Q000473:pathology / Q000601:surgery*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011664:Pulmonary Valve / Q000002:abnormalities* / Q000601:surgery*; D016896:Treatment Outcome; D014261:Tricuspid Valve / Q000002:abnormalities